Immunoassay Analyzers Market Size, Share & Trends Analysis Report By Product (CLIA, FIA), By Application (Therapeutic Drug Monitoring, Oncology, Cardiology), By End-use, By Region, And Segment Forecasts, 2024 - 2030
Immunoassay Analyzers Market Size, Share & Trends Analysis Report By Product (CLIA, FIA), By Application (Therapeutic Drug Monitoring, Oncology, Cardiology), By End-use, By Region, And Segment Forecasts, 2024 - 2030
Immunoassay Analyzers Market Trends
The global immunoassay analyzers market size was valued at USD 7.61 billion in 2023 and is projected to grow at a CAGR of 3.2% from 2024 to 2030. An increase in incidences of chronic diseases, such as infectious and noninfectious diseases, is the primary factor driving the market growth. Technological innovations and applications of immunoassay are rapidly expanding due to diseases such as cancer and cardiology.
The rise in the number of chronic and infectious diseases is a leading cause of market growth for immunoassay analyzers. The rising number of cardiology and cancer cases is contributing to the development of new and advanced treatment options, and companies are innovating new treatments. The WHO reported 20 million new cases of cancer in 2022 and has projected the estimated number of cancer diagnoses to 53.5 million.
During the outbreak of the COVID-19 pandemic, the SARS-CoV-2 virus created an urgent need for an accelerated diagnosis, promising precision and affordability combined in one method. RT-PCR tests were conducted for early diagnosis but were considered an expensive approach. That drove immunoassay analyzers to be deployed to detect antibodies for quick and cost-effective methods. For instance, Agilent Technologies, Inc. launched Agilent Dako SARS-CoV-2, an enzyme-linked immunoassay kit to detect SARS-CoV-2 antibodies in human serum or plasma. The pandemic brought awareness of immunoassay analyzers in the market and accelerated technological developments.
The rise in chronic diseases has led to technological advancements in immunoassay analyzers. Emerging diseases, antibiotic resistance, and the demand for personalized medicine drive the advancements of sensitive, specific, and rapid immunoassay tests. Various companies are coming up with technological solutions to fulfill this demand for treatment. For instance, Diamond Diagnostics is ensuring healthcare providers access to advanced immunoassay diagnostics through the manufacturing of high-quality and cost-effective consumables and accessories products of immunoassay analyzers. Such innovations are expected to drive market growth.
The rise in collaboration activities of various companies is another driving factor for market growth. For instance, Beckman Coulter, Inc. and Fujirebio partnered in July 2023 to strengthen respective immunoassay capabilities to support therapeutic advancement, clinical trials, routine clinical adoption, and reimbursement in neurodegenerative diseases. Such partnerships are driving the market growth of immunoassay analyzers.
Global Immunoassay Analyzers Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global immunoassay analyzers market report based on product, application, end use, and region:
Product Outlook (Revenue, USD Million, 2018 - 2030)
Chemiluminescence Immunoassay (CLIA)
Fluorescence Immunoassay (FIA)
Radioimmunoassay
Enzyme-Linked Immunoassay
Consumables and Accessories
Application Outlook (Revenue, USD Million, 2018 - 2030)
Therapeutic Drug Monitoring
Oncology
Cardiology
Endocrinology
Infectious Disease Testing
Autoimmune Disease
Others
End Use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Diagnostic Laboratories
Research Institutes
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Asia Pacific
China
Japan
India
South Korea
Australia
Latin America
Brazil
Middle East and Africa (MEA)
KSA
UAE
South Africa
Please note The report will be delivered in 2-3 business days upon order notification.